FUL · Fuller H B Co
$50.20
-0.03 (-0.06%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$2.69B
Shares
53.83M
Volume · Oct 2
837.18K
Avg daily vol (3M)
784.07K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$50.23
Open$49.41
Day$48.54–50.48
52W close$49.29–67.49
Avg vol 30d845K
Short int2.9M · 5.4% float · 4.9d
Short vol57%
Last earningsSep 24, 2026
DataJan 2020–Oct 2026
Filing10-Q · Sep 24
Up next
Next earnings call
Dec 24, 2026
Est · unconfirmed
· in 12 wks
filed Sep 24, 2026
call held Sep 24, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$3.55B
Trailing 12 months
Net income (TTM)
$197.76M
Trailing 12 months
Revenue growth YoY
+5.2%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
14.0
Trailing earnings · reciprocal yield 7.1%
FCF yield
3.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.5%
Year over year · fewer shares
Price change (1Y)
-14.3%
Trailing year
Short interest
5.4%
Latest settlement · 4.9 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Very Bullish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 16.4 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−15%
below
Price vs 50-day avg
−9%
below
RSI (14)
38
neutral
MACD trend
Positive
52-week position
5%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−7%
trailing
6-month return
−21%
trailing
YTD return
−16%
this year
Relative strength
−34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $55 › 200d $59 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +62 funds added
Insider flow
Accumulating
Net +$28.0K over 90 days · 13% sells
Short interest
Falling
5.44% of float · ▼ -3.7% MoM · 4.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
353 holders — near 3-yr high, broad support
Squeeze score
57
elevated · 0–100
Fundamentals
Revenue growth
−5%
Y/Y
Gross margin
37%
expanding
EPS growth
+20%
Y/Y
Free cash flow
$121.2M
Valuation
P/E 14
below peers
Buyback
$211.0M
remaining
Balance sheet
$1.9B
net debt
Quant / Vol
risk profile
Volatility
34%
annualized · 1-yr
Max drawdown
−27%
past year
ATR
3.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Sep 24, 2026
Adjusted EBITDA
· fiscal 2026
Non-GAAP
Maintained
$655M – $670M
Jun 25, 2026
$650M – $675M
changed to
Sep 24, 2026
$655M – $670M
Core tax rate, excluding the impact of discrete items
· fiscal 2026
Non-GAAP
Initiated
25.5% – 26%
Adjusted EPS (diluted)
· fiscal 2026
Non-GAAP
Raised
$4.70 – $4.85
Jun 25, 2026
$4.60 – $4.90
changed to
Sep 24, 2026
$4.70 – $4.85
Prior guidance
period ended
· from the 8-K filed Jun 25, 2026
Adjusted EBITDA
· third quarter of 2026
$180M – $190M
Guided vs delivered
· last 1 settled
Net revenue
fiscal 2023
guided $3.5B – $3.55B
$3.51B
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−15%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
38
Neutral
MACD trend
Positive
Bullish
52-week position
5%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross)
No cross
50d $55 › 200d $59 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +62 funds added
Insider flow
Accumulating
Net +$28.0K over 90 days · 13% sells
Short interest
Falling
5.44% of float · ▼ -3.7% MoM · 4.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
353 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $49
Now $50 · 5%
Range high $67
vs 200-day avg -15%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted income per common share attributable to H.B. Fuller non-GAAP | $3.49 | Nine Months Ended August 29, 2026 | — |
| Adjusted EBITDA non-GAAP | 656.51M | Trailing Twelve Months Ended August 29, 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 18.3% | Nine Months Ended August 29, 2026 | — |
| Adjusted effective income tax rate non-GAAP | 25.7% | Nine Months Ended August 29, 2026 | — |
| Adjusted gross profit non-GAAP | $315M | Q3 FY2026 | — |
| Adjusted gross profit margin non-GAAP | 33.1% | Nine Months Ended August 29, 2026 | — |
| Adjusted net income attributable to H.B. Fuller non-GAAP | 192.48M | Nine Months Ended August 29, 2026 | — |
|
|
|||
| Adjusted SG&A non-GAAP | $183M | Q3 FY2026 | — |
| Net debt non-GAAP | $1.96B | Q3 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Total debt 2.05B
-97.23M Less: Cash and cash equivalents
= Net debt 1.96B
|
|||
| Net Debt-to-Adjusted EBITDA non-GAAP | 3 | August 29, 2026 | — |
| Net working capital non-GAAP | 693.53M | August 29, 2026 | — |
| Net working capital as a percentage of annualized net revenue non-GAAP | 18.5% | Q3 FY2026 | — |
| Organic Growth non-GAAP | 0.4% | Nine Months Ended August 29, 2026 | — |
| Segment adjusted EBITDA margin non-GAAP | 23.8% | Three Months Ended August 29, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FUL
this stock
Fuller H B Co
|
$2.69B | -15.5% | -4.7% | 14.0 | 5.4% |
|
LIN
Linde PLC
|
$216.61B | +10.1% | +3.0% | 30.3 | 1.3% |
|
AIQUF
L Air Liquide SA /Fi
|
$121.25B | -1.1% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$79.89B | -1.0% | +2.1% | 30.4 | 2.6% |
|
ECL
Ecolab Inc.
|
$78.35B | +3.3% | +2.2% | 37.5 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FUL | +0.5% | -6.8% | -21.2% | +1.5% | -15.5% |
| SPY | -0.4% | -0.2% | +12.4% | +0.2% | +12.0% |
| vs SPY | +0.9% | -6.7% | -33.6% | +1.4% | -27.6% |
Capital returns
Declared · upcoming
$0.245
/ share · ex Oct 15, 2026
Paid (TTM)
$0.00
/ share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Buyback program
· as of Nov 29, 2025
Authorized
$300.00M
Spent (derived)
$89.00M
Remaining
$211.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.